Braun Stacey Associates’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.8M Buy
236,042
+13,549
+6% +$1.39M 0.76% 55
2025
Q4
$23.6M Sell
222,493
-1,180
-0.5% -$137K 0.77% 56
2025
Q3
$28.4M Buy
223,673
+18,967
+9% +$2.26M 0.93% 34
2025
Q2
$25.1M Buy
204,706
+81,501
+66% +$9.31M 0.91% 40
2025
Q1
$12.5M Buy
123,205
+18,298
+17% +$1.79M 0.51% 75
2024
Q4
$9.69M Buy
+104,907
New +$10.3M 0.36% 85

Other funds holding EHC

Braun Stacey Associates's EHC Position: Q1 2026 in Review

Braun Stacey Associates increased its Encompass Health (EHC) stake by 6.1% in Q1 2026, buying an estimated $1.39M and bringing the position to 236,042 shares worth $22.8M. The position accounts for 0.76% of the portfolio, ranked #55.

Braun Stacey Associates first reported a position in EHC in Q4 2024 and has held it in 6 quarters since. The position peaked at $28.4M in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Braun Stacey Associates held 236,042 shares of Encompass Health worth $22.8M as of Q1 2026.
  • Braun Stacey Associates bought 13,549 Encompass Health shares in Q1 2026, an estimated $1.39M.
  • Encompass Health made up 0.76% of Braun Stacey Associates's portfolio in Q1 2026, its #55 holding.
  • Braun Stacey Associates first reported a position in Encompass Health in Q4 2024 and has held it in 6 quarters since.
  • Braun Stacey Associates's Encompass Health position peaked at $28.4M in Q3 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Braun Stacey Associates's 13F filing for Q1 2026, filed 22 Apr 2026.